Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Clinical, preclinical efficacy of Neovastat featured at recent congress

Oct. 27, 1998

Temodal recommended for approval in E.U.

Oct. 27, 1998

STAR study will compare raloxifene to tamoxifen for reducing risk of breast cancer

Oct. 26, 1998

Thalidomide designated orphan drug for multiple myeloma

Oct. 26, 1998

Camptosar receives final FDA approval for colorectal cancer

Oct. 26, 1998

Naamidine A identified as EGF receptor antagonist and antiproliferative agent

Oct. 26, 1998

Nonsteroid progesterone antagonists for cancer, gynecological disorders

Oct. 26, 1998

Beta-glucuronidase inhibitors as antitumor/antiinflammatory agents

Oct. 26, 1998

Potent antitumor activity, low toxicity observed in in vitro studies of aplidine

Oct. 23, 1998

Cell Therapeutics initiates phase I lisofylline trial for treatment of mucositis

Oct. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...